Table 3.
Country | CRNA % | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|
Australia | 6.8 | 2.37 (1.14 to 3.98) | 2.17 (1.29 to 3.68) |
Canada | 8.3 | 2.92 (1.77 to 4.84) | 2.76 (1.66 to 4.59) |
France | 1.6 | 0.54 (0.27 to 1.08) | 0.47 (0.24 to 0.95) |
Germany | 3.7 | 1.22 (0.64 to 2.33) | 1.00 (0.52 to 1.91) |
Netherlands | 4.0 | 1.35 (0.72 to 2.53) | 1.19 (0.63 to 2.24) |
New Zealand | 4.8 | 1.62 (0.85 to 3.10) | 1.69 (0.88 to 3.24) |
Norway | 2.4 | 0.80 (0.41 to 1.59) | 0.66 (0.33 to 1.31) |
Sweden | 2.4 | 0.78 (0.47 to 1.32) | 0.80 (0.47 to 1.36) |
Switzerland | 2.9 | 0.97 (0.54 to 1.75) | 0.86 (0.48 to 1.57) |
UK | 3.1 | Reference | Reference |
USA | 16.8 | 6.47 (3.89 to 10.78) | 6.10 (3.64 to 10.20) |
Results reported in bold are significant at p=0.05. Adjusted ORs based on sample-weighted logistic regression models that control for age group, sex, health status and household income.
CRNA, cost-related non-adherence, sample-weighted prevalence.